Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Davood Bashash

Showing results (71-80 of 185) with videos related to

Pageof 19
Sort By:
The International Journal of Biochemistry & Cell Biology|September 21, 2019
Inhibition of PI3K pathway using BKM120 intensified the chemo-sensitivity of breast cancer cells to arsenic trioxide (ATO)Faranak Alipour, Niknam Riyahi, Ava Safaroghli-Azar, et al.
Hematology (Amsterdam, Netherlands)|January 6, 2017
Inhibition of telomerase using BIBR1532 enhances doxorubicin-induced apoptosis in pre-B acute lymphoblastic leukemia cellsDavood Bashash, Mohadeseh Zareii, Ava Safaroghli-Azar, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|May 2, 2018
Centaurea albonitens extract enhances the therapeutic effects of Vincristine in leukemic cells by inducing apoptosisForouzan Bahmani, Somayeh Esmaeili, Davood Bashash, et al.
Galen Medical Journal|September 1, 2021
Breast Cancer Interaction Network Concept from Mostly Related ComponentsMostafa Rezaei-Tavirani, Mona Zamanian-Azodi, Davood Bashash, et al.
Journal of Cancer Research and Clinical Oncology|August 18, 2023
Inhibitors of the PI3K/AKT/mTOR pathway in human malignancies; trend of current clinical trialsZeinab Davoodi-Moghaddam, Farideh Jafari-Raddani, Mahda Delshad, et al.
IUBMB Life|November 20, 2020
Toll-like receptors (TLRs) in cancer; with an extensive focus on TLR agonists and antagonistsAli Keshavarz, Atieh Pourbagheri-Sigaroodi, Parisa Zafari, et al.
International Immunopharmacology|March 25, 2021
The contributory role of lymphocyte subsets, pathophysiology of lymphopenia and its implication as prognostic and therapeutic opportunity in COVID-19Mahda Delshad, Naeimeh Tavakolinia, Atieh Pourbagheri-Sigaroodi, et al.
International Immunopharmacology|July 25, 2021
Platelets in the perspective of COVID-19; pathophysiology of thrombocytopenia and its implication as prognostic and therapeutic opportunityMahda Delshad, Ava Safaroghli-Azar, Atieh Pourbagheri-Sigaroodi, et al.
European Journal of Pharmacology|October 15, 2018
Inhibition of PI3K signaling pathway enhances the chemosensitivity of APL cells to ATO: Proposing novel therapeutic potential for BKM120Davood Bashash, Mahda Delshad, Niknam Riyahi, et al.
The International Journal of Biochemistry & Cell Biology|January 15, 2019
Small molecule inhibitor of c-Myc 10058-F4 inhibits proliferation and induces apoptosis in acute leukemia cells, irrespective of PTEN statusDavood Bashash, Mohamad Sayyadi, Ava Safaroghli-Azar, et al.
Pageof 19

Showing results (71-80 of 185) with videos related to

Sort By:
Pageof 19
The International Journal of Biochemistry & Cell Biology|September 21, 2019
Inhibition of PI3K pathway using BKM120 intensified the chemo-sensitivity of breast cancer cells to arsenic trioxide (ATO)Faranak Alipour, Niknam Riyahi, Ava Safaroghli-Azar, et al.
Hematology (Amsterdam, Netherlands)|January 6, 2017
Inhibition of telomerase using BIBR1532 enhances doxorubicin-induced apoptosis in pre-B acute lymphoblastic leukemia cellsDavood Bashash, Mohadeseh Zareii, Ava Safaroghli-Azar, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|May 2, 2018
Centaurea albonitens extract enhances the therapeutic effects of Vincristine in leukemic cells by inducing apoptosisForouzan Bahmani, Somayeh Esmaeili, Davood Bashash, et al.
Galen Medical Journal|September 1, 2021
Breast Cancer Interaction Network Concept from Mostly Related ComponentsMostafa Rezaei-Tavirani, Mona Zamanian-Azodi, Davood Bashash, et al.
Journal of Cancer Research and Clinical Oncology|August 18, 2023
Inhibitors of the PI3K/AKT/mTOR pathway in human malignancies; trend of current clinical trialsZeinab Davoodi-Moghaddam, Farideh Jafari-Raddani, Mahda Delshad, et al.
IUBMB Life|November 20, 2020
Toll-like receptors (TLRs) in cancer; with an extensive focus on TLR agonists and antagonistsAli Keshavarz, Atieh Pourbagheri-Sigaroodi, Parisa Zafari, et al.
International Immunopharmacology|March 25, 2021
The contributory role of lymphocyte subsets, pathophysiology of lymphopenia and its implication as prognostic and therapeutic opportunity in COVID-19Mahda Delshad, Naeimeh Tavakolinia, Atieh Pourbagheri-Sigaroodi, et al.
International Immunopharmacology|July 25, 2021
Platelets in the perspective of COVID-19; pathophysiology of thrombocytopenia and its implication as prognostic and therapeutic opportunityMahda Delshad, Ava Safaroghli-Azar, Atieh Pourbagheri-Sigaroodi, et al.
European Journal of Pharmacology|October 15, 2018
Inhibition of PI3K signaling pathway enhances the chemosensitivity of APL cells to ATO: Proposing novel therapeutic potential for BKM120Davood Bashash, Mahda Delshad, Niknam Riyahi, et al.
The International Journal of Biochemistry & Cell Biology|January 15, 2019
Small molecule inhibitor of c-Myc 10058-F4 inhibits proliferation and induces apoptosis in acute leukemia cells, irrespective of PTEN statusDavood Bashash, Mohamad Sayyadi, Ava Safaroghli-Azar, et al.
Pageof 19